Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ryder

Showing results (251-260 of 266) with videos related to

Pageof 27
Sort By:
Trials|September 27, 2022
ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis-study protocol for an interventional randomised controlled trialDominic Crocombe, Norin Ahmed, Indran Balakrishnan, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2026
Disordered Bile Acid Metabolism in Alcohol-Related HepatitisLuke D Tyson, Stephen Atkinson, Benjamin H Mullish, et al.
Wellcome Open Research|August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis CGraham S Cooke, Sarah Pett, Leanne McCabe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2006
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trialsJ Franklin, A Pluetschow, M Paus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up callRichard S Tedder, Alison J Rodger, Lori Fries, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysisJörn M Schattenberg, Jeffrey V Lazarus, Philip N Newsome, et al.
AIDS (London, England)|May 31, 2024
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIVLeanne McCabe, James E Burns, Arash Latifoltojar, et al.
Journal of Hepatology|June 14, 2019
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysisSergio M Borgia, Janet Dearden, Eric M Yoshida, et al.
BMJ (Clinical Research Ed.)|August 2, 2023
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort studyVictoria Hamill, Stanley Wong, Jennifer Benselin, et al.
Nature|May 17, 2023
A radio-detected type Ia supernova with helium-rich circumstellar materialErik C Kool, Joel Johansson, Jesper Sollerman, et al.
Pageof 27

Showing results (251-260 of 266) with videos related to

Sort By:
Pageof 27
Trials|September 27, 2022
ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis-study protocol for an interventional randomised controlled trialDominic Crocombe, Norin Ahmed, Indran Balakrishnan, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2026
Disordered Bile Acid Metabolism in Alcohol-Related HepatitisLuke D Tyson, Stephen Atkinson, Benjamin H Mullish, et al.
Wellcome Open Research|August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis CGraham S Cooke, Sarah Pett, Leanne McCabe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2006
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trialsJ Franklin, A Pluetschow, M Paus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up callRichard S Tedder, Alison J Rodger, Lori Fries, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2021
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysisJörn M Schattenberg, Jeffrey V Lazarus, Philip N Newsome, et al.
AIDS (London, England)|May 31, 2024
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIVLeanne McCabe, James E Burns, Arash Latifoltojar, et al.
Journal of Hepatology|June 14, 2019
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysisSergio M Borgia, Janet Dearden, Eric M Yoshida, et al.
BMJ (Clinical Research Ed.)|August 2, 2023
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort studyVictoria Hamill, Stanley Wong, Jennifer Benselin, et al.
Nature|May 17, 2023
A radio-detected type Ia supernova with helium-rich circumstellar materialErik C Kool, Joel Johansson, Jesper Sollerman, et al.
Pageof 27